TWT-101: A phase 1 study of the novel HPK1 inhibitor CFI-402411 in patients with advanced cancer

Category Primary study
JournalJournal for ImmunoTherapy of Cancer
Year 2021
This article has no abstract
Epistemonikos ID: 84047682c9fdee318930d0aaadc9bf7bc0dda3f4
First added on: Feb 13, 2025